In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tract.

"Conflict of interest The research presented in this publication was financed by DHU-Arzneimittel GmbH & Co KG, Karlsruhe, Germany (DHU).: Susann Buchheim-Schmidt and Petra Klement are employees of DHU.: Uwe Peters received an advisory fee from DHU.: Cindy Duysburgh, Pieter Van den Abbeele and Massimo Marzorati are employees of Prodigest. ProDigest received payment from DHU for conducting the research and analysing the data.: Thomas Keller is owner of ACOMED statistik. ACOMED statistik received payment from DHU for statistical analysis of the study.: David Martin and Stephan Baumgartner report no conflict of interest."

"Funding This investigation was funded by institutional resources only (DHU-Arzneimittel GmbH & Co KG) and received no further third-party funding."